David Vigerust
Last active: 12/2/2016

Profile

My interests focus around areas of healthcare, PGx, and diagnositics.  I am trained in immunology and infectious disease.

My other interests include infectious disease, oncology, innate immunity, traumatic brain injury, neuro-oncology (meningioma and glioma), neuroinflammation, neurodegeneration (ALS, Multiple Sclerosis, Muscular Distrophy and Spinal Muscular Atrophy) and polymicrobial approaches to improved biofuels.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis. Bale BF, Doneen AL, Vigerust DJ (2017) Postgrad Med J 93(1098): 215-220
    › Primary publication · 27899684 (PubMed) · PMC5520251 (PubMed Central)
  2. Role of Haptoglobin in Health and Disease: A Focus on Diabetes. MacKellar M, Vigerust DJ (2016) Clin Diabetes 34(3): 148-57
    › Primary publication · 27621532 (PubMed) · PMC5019011 (PubMed Central)
  3. Hp: an inflammatory indicator in cardiovascular disease. Graves KL, Vigerust DJ (2016) Future Cardiol 12(4): 471-81
    › Primary publication · 27203711 (PubMed)
  4. Stable Expression and Characterization of an Optimized Mannose Receptor. Vigerust DJ, Vick S, Shepherd VL (2015) J Clin Cell Immunol 6(3)
    › Primary publication · 26581716 (PubMed) · PMC4645283 (PubMed Central)
  5. Interaction of members of the heat shock protein-70 family with the macrophage mannose receptor. Yang S, Vigerust DJ, Shepherd VL (2013) J Leukoc Biol 93(4): 529-36
    › Primary publication · 23345393 (PubMed) · PMC3597836 (PubMed Central)
  6. Characterization of functional mannose receptor in a continuous hybridoma cell line. Vigerust DJ, Vick S, Shepherd VL (2012) BMC Immunol : 51
    › Primary publication · 22967244 (PubMed) · PMC3495026 (PubMed Central)
  7. First complete and productive cell culture model for members of the genus Iridovirus. D'Costa SM, Vigerust DJ, Perales-Hull MR, Lodhi SA, Viravathana P, Bilimoria SL (2012) Arch Virol 157(11): 2171-8
    › Primary publication · 22828780 (PubMed)
  8. Mitogen-activated protein kinases and NFkappaB are involved in SP-A-enhanced responses of macrophages to mycobacteria. Lopez JP, Vigerust DJ, Shepherd VL (2009) Respir Res : 60
    › Primary publication · 19566962 (PubMed) · PMC2717924 (PubMed Central)
  9. Chloroquine is effective against influenza A virus in vitro but not in vivo. Vigerust DJ, McCullers JA (2007) Influenza Other Respir Viruses 1(5-6): 189-92
    › Primary publication · 19453426 (PubMed) · PMC4941887 (PubMed Central)
  10. N-linked glycosylation attenuates H3N2 influenza viruses. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA (2007) J Virol 81(16): 8593-600
    › Primary publication · 17553891 (PubMed) · PMC1951338 (PubMed Central)
  11. Virus glycosylation: role in virulence and immune interactions. Vigerust DJ, Shepherd VL (2007) Trends Microbiol 15(5): 211-8
    › Primary publication · 17398101 (PubMed)
  12. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor. Vigerust DJ, Egan BS, Shepherd VL (2005) J Leukoc Biol 77(4): 522-34
    › Primary publication · 15637102 (PubMed)
  13. Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase. Gelderman MP, Stuart R, Vigerust D, Fuhrmann S, Lefkowitz DL, Allen RC, Lefkowitz SS, Graham S (1998) Mediators Inflamm 7(6): 381-9
    › Primary publication · 9927230 (PubMed) · PMC1781873 (PubMed Central)